About Julphar
Julphar is a publicly listed company based in Ras Al Khaimah (United Arab Emirates) founded in 1980. Pharmaceuticals, vaccines, and consumer healthcare products are manufactured by Julphar. Julphar has completed 2 acquisitions, including Planet Pharmacies and RAK Pharmaceuticals. Its chief executive, as recorded, is Basel Ziyadeh. Its website julphar.net draws about 11 thousand monthly visits. Julphar offers products and services including Medicines and Vaccines. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Gulf Pharmaceutical Industries.
Company details
Julphar was established in 1980 in Ras Al-Khaimah, United Arab Emirates. Pharmaceuticals, vaccines, and consumer healthcare products are produced, with medicines developed for various health conditions. A training center recognized by ILM (International Leadership Management - UK) is maintained, where technical and soft skills training is delivered to healthcare professionals. The healthcare sectors workforce is supported through this internal program.
- Annual Revenue$1.08 B8.4as on Dec 31, 2025
- Net Profit$61 M771.43as on Dec 31, 2025
- EBITDA$109.5 M-37.07as on Dec 31, 2025
- Investments & AcquisitionsPlanet Pharmacies
& 1 more
Products & Services of Julphar
Julphar offers a comprehensive portfolio of products and services, including Medicines and Vaccines.
Medicines for various health conditions are produced by Julphar
Vaccines and consumer healthcare products are manufactured by Julphar for a range of applications
Apps and channels of Julphar
its YouTube channel Julphar UAE has 1.14K subscribers and 29 videos.
Videos from Julphar
The most watched videos on Julphar's YouTube channel, Julphar UAE (1.14K subscribers). Click a video to play it here.
More on Julphar UAE.
People of Julphar
76 people are tracked at Julphar (18 in leadership, 58 in team).
| Name | Role | Group |
|---|---|---|
Basel Ziyadeh | CEO | Leadership |
Ammar Murjan | Head Of Maintenance | Leadership |
Boualem Djoufelkit | Country Director Algeria & Morocco | Leadership |
Ahmed Elbakry | Country Head | Leadership |
Malik Metahri | Chief Technical Officer | Leadership |
Mohamed Elsharaby | Marketing Director – Cardiometabolic, Anemia & CNS | Leadership |
Arun Kant Joshi | Director | Leadership |
Mohammed Kamruzzaman Bhuiyan | Senior Manager And Head Of Formulation, Research And Development At Gulf Pharmaceutical Industry | Leadership |
Tareq al-Subaih | Senior Manager Of Mechanical Maintenance Department / Head Of Department | Leadership |
Maged Mina | Director | Leadership |
Emadeldin Dr. Farahat | Director Sales & Marketing | Leadership |
Omar Mansour | Talent Acquisition Partner | Leadership |
Srinivasa N | Head Of Information Technology | Leadership |
Hamdy Elnoor | Sales Operation And Logistic Director, Julphar | Leadership |
Jürgen Lauterbach | Chief Corporate Development & Strategy Officer | Leadership |
Fatima Alshehhi | Office Manager Of CEO | Leadership |
G Kumar | Chief Human Resources Officer | Leadership |
Mahmoud Hafez | Head Of Technical Operations | Leadership |
Afzal Pasha | SAP Basis HANA Manager | Team |
Sahaya Anbarasu | Sterile Quality Assurance Specialist | Team |
56 more people are available in the full profile.
Complete people profiles for Julphar
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Julphar
Julphar is a publicly listed company on the ADX with ticker symbol JULPHAR in UAE, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Oct 2002
- Listed onADSM: JULPHAR
- Listed entityGulf Pharmaceutical Industries
- Exchange sectorHealth technology
- ISINAEG000201018
- Share price1.00 AED (-1.96% on the day) · 2026-10-14
- Market capitalisation1,178,332,317.00 AED
- Price to earnings14.0
- EPS (diluted, trailing year)0.07 AED
- Volume (last session)365,754
Financials of Julphar
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.08B AED | 61.0M AED | 109.5M AED |
| 2024 | 992.2M AED | 7.0M AED | 174.0M AED |
| 2023 | 1.28B AED | -99.1M AED | 108.4M AED |
| 2022 | 1.62B AED | -29.4M AED | 34.3M AED |
| 2021 | 1.14B AED | 36.4M AED | 40.3M AED |
Detailed financial statements for Julphar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Julphar
Julphar has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Planet Pharmacies and RAK Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical products are distributed and retailed across the Middle East. | planetme.ae | Dubai, United Arab Emirates | 2007 | Jun 2021 | •••• | |
Tablets, capsules, and syrups are manufactured by RAK Pharmaceuticals. | rakpharma.com | Dhaka, Bangladesh | 2009 | Feb 2015 | $9.5M |
Complete acquisition details for Julphar
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Julphar
4 dated milestones of Julphar across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Julphar is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires RAK Pharmaceuticals.
- Acquisition Acquires Planet Pharmacies.
Web traffic of Julphar
The website of Julphar (julphar.net) receives about 10.8K visits a month and ranks #898,528 among all websites worldwide, #1,078 in Biotechnology and Pharmaceuticals.
- Monthly visits10.8K
▼ 65.1% vs previous month
- Unique visitors13.7K
per month
- Global rank#898,528
among all websites
- Category rank#1,078
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit2.3
- Average visit49 sec
- DevicesDesktop 20% · Mobile 80%
Websites whose visitors overlap most with Julphar. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mspharma.com | 100% | 12.4K | #1,443,733 | View details | |
| dadgroup.com | 95% | 680.7K | #3,450,381 | View details | |
| leo-pharma.com | 92% | 90.7K | #474,135 | View details | |
| tabukpharmaceuticals.com | 92% | 28.7K | #1,212,851 | View details | |
| sajapharma.com | 91% | #2,534,807 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Julphar
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Julphar
Complete news archive for Julphar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Julphar
Julphar was founded in 1980.
Julphar is headquartered in Ras Al Khaimah, United Arab Emirates. It is registered at Ras Al Khaimah, Ras Al Khaimah, United Arab Emirates.
Basel Ziyadeh is the CEO of Julphar, as recorded in our data.
Julphar was established in 1980 in Ras Al-Khaimah, United Arab Emirates. Pharmaceuticals, vaccines, and consumer healthcare products are produced, with medicines developed for various health conditions. A training center recognized by ILM (International Leadership Management - UK) is maintained, where technical and soft skills training is delivered to healthcare professionals. The healthcare sectors workforce is supported through this internal program.
Julphar offers Medicines and Vaccines.
Yes, Julphar is publicly traded on ADX under the ticker symbol JULPHAR.
Julphar has made 2 acquisitions, including Planet Pharmacies, and RAK Pharmaceuticals.
Julphar operates through Gulf Pharmaceutical Industries.